Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Kabra Drugs Limited (KABRADG.BO)

Compare
11.08
0.00
(0.00%)
At close: 10:45:15 AM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Expense
14,134.21
7,281.21
3,439.67
1,852.85
1,800.30
Operating Income
-14,134.21
-7,281.21
-3,439.67
-1,852.85
-1,800.30
Net Non Operating Interest Income Expense
-5.47
-5.47
60.66
-1.09
--
Pretax Income
-14,140.68
-7,286.68
-3,379
-1,853.94
-1,800.30
Net Income Common Stockholders
-14,214.94
-7,360.94
-3,379
-1,853.94
-1,800.30
Diluted NI Available to Com Stockholders
-14,214.94
-7,360.94
-3,379
-1,853.94
-1,800.30
Basic EPS
-2.30
-1.66
-0.77
-0.42
-0.41
Diluted EPS
-2.30
-1.66
-0.77
-0.42
-0.41
Basic Average Shares
23,707.85
4,388.60
4,388.60
4,388.60
4,388.60
Diluted Average Shares
23,707.85
4,388.60
4,388.60
4,388.60
4,388.60
Rent Expense Supplemental
--
355.80
234
235
216
Total Expenses
14,134.21
7,281.21
3,439.67
1,852.85
1,800.30
Net Income from Continuing & Discontinued Operation
-14,214.94
-7,360.94
-3,379
-1,853.94
-1,800.30
Normalized Income
-14,214.94
-7,360.94
-3,379
-1,853.94
-1,800.30
Interest Income
--
--
63.76
--
--
Net Interest Income
-5.47
-5.47
60.66
-1.09
--
EBIT
-14,140.68
-7,286.68
-3,379
-1,853.94
-1,800.30
EBITDA
-14,135.68
-7,286.68
-3,379
-1,754.15
-1,487.74
Reconciled Depreciation
5
--
--
99.79
312.57
Net Income from Continuing Operation Net Minority Interest
-14,214.94
-7,360.94
-3,379
-1,853.94
-1,800.30
Normalized EBITDA
-14,135.68
-7,286.68
-3,379
-1,754.15
-1,487.74
3/31/2021 - 12/30/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers